ArticleMedical science monitor : international medical journal of experimental and clinical research2018

Pretreatment with Erythropoietin Attenuates Lung Ischemia/Reperfusion Injury via Toll-Like Receptor-4/Nuclear Factor-κB (TLR4/NF-κB) Pathway.

Qian He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.